Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. The power of your gut
  3. (Super) bacterium may help better predict effectiveness of lung cancer treatment
  • Learn all about microbiota
    • The gut microbiota
    • The ENT microbiota
    • The pulmonary microbiota
    • The urinary microbiota
    • The skin microbiota
    • The vaginal microbiota
  • Microbiota and related conditions
    • Digestive disorders
    • Women disorders
    • Metabolic disorders
    • Skin disorders
    • Pediatric disorders
    • Psychiatric disorders
    • Neurological disorders
    • Respiratory disorders
    • Urinary disorders
  • Act on your microbiota
    • Probiotics
    • Prebiotics
    • Fecal Microbiota Transplant
    • Diet
  • Publications
    • News
    • Thematics folders
    • Thematic pages
    • Microbiota Q & A
    • Patients Stories
    • Experts' point of view
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Healthcare professionals section

Find here your dedicated section
Biocodex logo
The power of your gut
My microbiota as a woman
Our marvelous microbiota

Breadcrumb

  1. Home
  2. The power of your gut
  3. (Super) bacterium may help better predict effectiveness of lung cancer treatment
The power of your gut

(Super) bacterium may help better predict effectiveness of lung cancer treatment

Cancer
The gut microbiota

Predicting the effectiveness of treatments for diseases such as cancer is no easy task. This may all change thanks to promising research on the bacterium Akkermansia muciniphila (Akk). Further details on this (very) beneficial bacterium below.

The power of your gut
My microbiota as a woman
Our marvelous microbiota
  • Learn all about microbiota
    • The gut microbiota
    • The ENT microbiota
    • The pulmonary microbiota
    • The urinary microbiota
    • The skin microbiota
    • The vaginal microbiota
  • Microbiota and related conditions
    • Digestive disorders
    • Women disorders
    • Metabolic disorders
    • Skin disorders
    • Pediatric disorders
    • Psychiatric disorders
    • Neurological disorders
    • Respiratory disorders
    • Urinary disorders
  • Act on your microbiota
    • Probiotics
    • Prebiotics
    • Fecal Microbiota Transplant
    • Diet
  • Publications
    • News
    • Thematics folders
    • Thematic pages
    • Microbiota Q & A
    • Patients Stories
    • Experts' point of view
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Healthcare professionals section

Find here your dedicated section
Biocodex logo

Sources

This article is based on scientific information

Sharing is caring

Your friends might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • Mail

About this article

Created 24 May 2022
Updated 14 May 2024

Immunotherapy is now a common treatment for non-small-cell lung cancer (NSCLC). However, only 35% of patients experience long-term benefits from this treatment. Identifying biomarkers of response to immunotherapy may thus improve patients’ chances of survival.

Akkermansia muciniphila under the spotlight

Researchers at the Gustave Roussy Cancer Institute in France had already shown that the presence of Akkermansia in the gut microbiota was associated with clinical benefits in patients treated with immunotherapy.

The work of Lisa Derosa’s team, the results of which were published in prestigious medical journal Nature Medicine in 2022, goes one step further. The team investigated Akkermansia’s potential as a predictive marker of survival and response to immunotherapy among NSCLC patients.

They monitored 338 patients undergoing immunotherapy for four years :

  • 131 had Akkermansia in their gut flora (Akk+)
  • and 207 did not (Akk-). Their conclusions are very promising.

The gut microbiota

Find out more

Better patient survival 

The first finding was that patients with Akkermansia in their microbiota responded better to treatment: the Akk+ group had an overall survival of 18.8 months, compared to 15.4 months for the Akk- group. 

Another finding was that, unlike the Akk- group, the Akk+ patients had greater microbial diversity in their microbiota, which included bacteria with recognized beneficial effects on health and immune status, such as bifidobacteria, Faecalibacterium prausnitzii and Eubacterium hallii. 

Unsurprisingly, antibiotic use had an adverse effect on overall survival for both the Akk+ and Akk- groups, confirming the link between the use of antibiotics and a poor clinical outcome.

Akkermansia is therefore of major interest. The bacterium may offer a new therapeutic approach targeting the microbiota, thus giving hope to NSCLC patients.
To be continued.

Recommended by our community

"Great news" - Peggy Rhinelander (From My health, my microbiota)

Sources

Derosa L, Routy B, Thomas AM, et al. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nat Med. 2022 Feb;28(2):315-324.

Tags
Immunotherapy Akkermansia muciniphila Cancer Microbiome Flora

    See also

    Actu PRO un lien etabli entre microbiote intestinal et infections respiratoires The role of intestinal microbiota in respiratory infections
    COPD: gut microbiota in the dock
    Created 24 May 2022
    Updated 14 May 2024

    About this article

    To know more about this topic.

    Main topic

    Cancer

    Related microbiotas

    The gut microbiota
    The power of your gut

    Microbiotalk : short conferences on antimicrobial resistance

    Breaking the silence: a global conversation on antimicrobial resistance Antimicrobial resistance (AM...

    Find out more

    Functional dyspepsia

    Despite its strange-sounding name, functional dyspepsia is a common digestive disorder. Characteristi...

    Find out more

    The gut microbiota

    Gut microbiota: why is it that important for your health? We have trillions1 of bacteria that po...

    Find out more

    Travelers’ diarrhea

    It's not what you think... Notice to globetrotters and travelers who’ve fallen victim to the dreaded...

    Find out more

    Fecal transplant: a promising route?

    This will surprise more than one person: using stool for therapeutic purposes did not start yesterday...

    Find out more

    Expert Interview : Dr Julie Lemale

    Dr. Julie Lemale is a Pediatric Gastroenterologist at the Armand Trousseau Hospital (AP-HP, Paris) an...

    Find out more

    Probiotics, a promising solution?

    Probiotics are “live microorganisms (bacteria, yeasts) that, upon ingestion in sufficient concentrati...

    Find out more

    Expert interview : Pr Patrice D. Cani

    Modulating the gut microbiota: effective for losing weight? While the study of gut microbiota opens ...

    Find out more

    Latest news

    News
    13.05.2025

    When sodas harm your microbiota and your health

    Read the article
    07.05.2025

    Downside of fruit and vegetable juices for gut health

    Read the article
    Allergies : et si tout venait du microbiote ?
    28.03.2023

    Allergies: and what if it all started with the microbiota?

    Read the article
    Photo LP: Sensibles à l’E466 ? Votre microbiote a son mot à dire
    15.04.2025

    Sensitive to E466? Your microbiota plays a role

    Read the article
    23.04.2024

    Bacterial diarrhea: the only case where antibiotics can be used

    Read the article
    Patients stories - logo
    21.11.2022

    Patients stories: living with Irritable Bowel Syndrome (IBS)

    Read the article
    Actu GP : Bière sans alcool, le microbiote intestinal en raffole !
    15.10.2019

    Non-alcoholic beer: the gut microbiota just loves it!

    Read the article
    Actu GP : Le régime méditerranéen contre la fragilité des seniors ?
    28.05.2020

    Does the Mediterranean diet protect the elderly against frailty?

    Read the article
    • Learn all about microbiota
      • The gut microbiota
      • The ENT microbiota
      • The pulmonary microbiota
      • The urinary microbiota
      • The skin microbiota
      • The vaginal microbiota
    • Microbiota and related conditions
      • Digestive disorders
      • Women disorders
      • Metabolic disorders
      • Skin disorders
      • Pediatric disorders
      • Psychiatric disorders
      • Neurological disorders
      • Respiratory disorders
      • Urinary disorders
    • Act on your microbiota
      • Probiotics
      • Prebiotics
      • Fecal Microbiota Transplant
      • Diet
    • Publications
      • News
      • Thematics folders
      • Thematic pages
      • Microbiota Q & A
      • Patients Stories
      • Experts' point of view
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Healthcare professionals section

    Find here your dedicated section
    Biocodex logo
    The power of your gut
    My microbiota as a woman
    Our marvelous microbiota
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Polish

    Browse the site

    • Learn all about microbiota
      • The gut microbiota
      • The ENT microbiota
      • The pulmonary microbiota
      • The urinary microbiota
      • The skin microbiota
      • The vaginal microbiota
    • Microbiota and related conditions
      • Digestive disorders
      • Women disorders
      • Metabolic disorders
      • Skin disorders
      • Pediatric disorders
      • Psychiatric disorders
      • Neurological disorders
      • Respiratory disorders
      • Urinary disorders
    • Act on your microbiota
      • Probiotics
      • Prebiotics
      • Fecal Microbiota Transplant
      • Diet
    • Publications
      • News
      • Thematics folders
      • Thematic pages
      • Microbiota Q & A
      • Patients Stories
      • Experts' point of view
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Healthcare professionals section

    Find here your dedicated section
    Biocodex logo

    Discover

    The power of your gut
    My microbiota as a woman
    Our marvelous microbiota

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Healthcare professionals section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the microbiota community and receive "The Essentials" once a month to stay up to date with the latest news on the microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    13.05.2025

    When sodas harm your microbiota and your health

    Read the article
    07.05.2025

    Downside of fruit and vegetable juices for gut health

    Read the article
    Photo LP: Sensibles à l’E466 ? Votre microbiote a son mot à dire
    15.04.2025

    Sensitive to E466? Your microbiota plays a role

    Read the article

    Stay updated

    Join the Microbiota Community and receive once a month “The Essential” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Learn all about microbiota
      • The gut microbiota
      • The ENT microbiota
      • The pulmonary microbiota
      • The urinary microbiota
      • The skin microbiota
      • The vaginal microbiota
    • Microbiota and related conditions
      • Digestive disorders
      • Women disorders
      • Metabolic disorders
      • Skin disorders
      • Pediatric disorders
      • Psychiatric disorders
      • Neurological disorders
      • Respiratory disorders
      • Urinary disorders
    • Act on your microbiota
      • Probiotics
      • Prebiotics
      • Fecal Microbiota Transplant
      • Diet
    • Publications
      • News
      • Thematics folders
      • Thematic pages
      • Microbiota Q & A
      • Patients Stories
      • Experts' point of view
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Healthcare professionals section

    Find here your dedicated section
    Biocodex logo

    Discover

    The power of your gut
    My microbiota as a woman
    Our marvelous microbiota

    Healthcare professionals section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo